Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2025 Earnings Call Transcript August 12, 2025

Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.38.

Operator: Good afternoon, and welcome to Spero Therapeutics Second Quarter 202 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded, and a replay will be available. You can find the information on the replay and further information related to today’s...